Kurum Yazarı "Aydın, Ahmet" Tıp Fakültesi İçin Listeleme
-
Fasciola hepatica case considered as cholangiocarcinoma on imaging
Aydın, Ahmet; Göktaş Aydın, Sabin; Karaalioğlu, Banu (Ankara Hematology Oncology Association, 2022)Fascioliasis is a zoonotic infection and causes fever, eosinophilia, nausea, and even a mass interpreted as a malignancy on imaging. The diagnosis of the disease is difficult because of the wide spectrum of clinical features. ... -
The optimal treatment approaches and prognostic factors in elderly patients with advanced stage biliary tract tumors
Göktaş Aydın, Sabin; Çakan Demirel, Burçin; Bilici, Ahmet; Yılmaz, Cansu; Topçu, Atakan; Aykan, Musa Barış; Kahraman, Seda; Atcı, Muhammed Mustafa; Akbıyık, Ilgın; Akgül, Fahri; Ölmez, Ömer Fatih; Aydın, Ahmet (Ankara Hematology Oncology Association, 2023)Introduction: There is a lack of evidence of the outcomes in elderly patients advanced stage biliary tract cancer due to the patients aged over 65 years are less than 25% in many prospective trials. We designed a retrospective ... -
Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide
Göktaş Aydın, Sabin; Kutlu, Yasin; Muğlu, Harun; Aydın, Ahmet; Açıkgöz, Özgür; Hamdard, Jamshid; Karcı, Ebru; Bilici, Ahmet; Ölmez, Ömer Fatih; Yıldız, Özcan (Springer, 2024)Background: Prostate cancer is a prevalent cancer in men worldwide, and castration-resistant prostate cancer (CRPC) is characterized by disease progression despite androgen deprivation therapy. While clinical and prognostic ... -
Survival effect of palliative radiotherapy in patients with metastatic castration-resistant prostate cancer developing oligo-progression under antiandrogen treatment
Göktaş Aydın, Sabin; Kutlu, Yasin; Muğlu, Harun; Açıkgöz, Özgür; Aydın, Ahmet; Bilici, Ahmet; Ölmez, Ömer Fatih; Ünal, Dilek; Karcı, Ebru; Yıldız, Özcan (Istanbul University, 2023)Objective: Androgen pathway inhibitors have a significant impact on the treatment of prostate cancer. The treatment approach is controversial in patients who develop oligo-pro-gression under anti-androgen therapy. This ...